| Literature DB >> 11958866 |
A Vezzani1, M Michalkiewicz, T Michalkiewicz, D Moneta, T Ravizza, C Richichi, M Aliprandi, F Mulé, L Pirona, M Gobbi, C Schwarzer, G Sperk.
Abstract
Functional studies in epileptic tissue indicate that neuropeptide Y and some of its peptide analogs potently inhibit seizure activity. We investigated seizure susceptibility in transgenic rats overexpressing the rat neuropeptide Y gene under the control of its natural promoter. Seizures were induced in adult transgenic male rats and their wild-type littermates by i.c.v. injection of 0.3 microg kainic acid or by electrical kindling of the dorsal hippocampus. Transgenic rats showed a significant reduction in the number and duration of electroencephalographic seizures induced by kainate by 30% and 55% respectively (P<0.05 and 0.01). Transgenic rats were also less susceptible to epileptogenesis than wild-type littermates as demonstrated by a 65% increase in the number of electrical stimuli required to induce stage 5 seizures (P<0.01). This phenotype was associated with a strong and specific expression of neuropeptide Y mRNA in area CA1, a brain area involved in the seizure network. We conclude that endogenous neuropeptide Y overexpression in the rat hippocampus is associated with inhibition of seizures and epileptogenesis suggesting that this system may be a valuable target for developing novel antiepileptic treatments.Entities:
Mesh:
Substances:
Year: 2002 PMID: 11958866 DOI: 10.1016/s0306-4522(01)00581-4
Source DB: PubMed Journal: Neuroscience ISSN: 0306-4522 Impact factor: 3.590